Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Updating images #123

Merged
merged 6 commits into from
Oct 24, 2024
Merged
Show file tree
Hide file tree
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
70 changes: 39 additions & 31 deletions fsh-generated/fsh-index.json
Original file line number Diff line number Diff line change
Expand Up @@ -53,7 +53,15 @@
"fshType": "Instance",
"fshFile": "oBDS\\18_19_Tumorkonferenz\\mii-exa-onko-tumorkonferenz-01.fsh",
"startLine": 1,
"endLine": 13
"endLine": 11
},
{
"outputFile": "CarePlan-mii-exa-onko-tumorkonferenz-02.json",
"fshName": "mii-exa-onko-tumorkonferenz-02",
"fshType": "Instance",
"fshFile": "oBDS\\18_19_Tumorkonferenz\\mii-exa-onko-tumorkonferenz-01.fsh",
"startLine": 13,
"endLine": 27
},
{
"outputFile": "CodeSystem-mii-cs-onko-allgemeiner-leistungszustand-ecog.json",
Expand Down Expand Up @@ -1253,7 +1261,7 @@
"fshType": "Profile",
"fshFile": "oBDS\\12_Allgemeiner_Leistungszustand\\mii-pr-onko-allgemeiner-leistungszustand.fsh",
"startLine": 1,
"endLine": 52
"endLine": 49
},
{
"outputFile": "StructureDefinition-mii-pr-onko-anzahl-befallene-lymphknoten.json",
Expand Down Expand Up @@ -1293,7 +1301,7 @@
"fshType": "Profile",
"fshFile": "oBDS\\06_Histologie\\mii-pr-onko-befund.fsh",
"startLine": 1,
"endLine": 34
"endLine": 36
},
{
"outputFile": "StructureDefinition-mii-pr-onko-diagnose-primaertumor.json",
Expand All @@ -1309,31 +1317,31 @@
"fshType": "Profile",
"fshFile": "oBDS\\11_Fernmetastasen\\mii-pr-onko-fernmetastasen.fsh",
"startLine": 1,
"endLine": 43
"endLine": 45
},
{
"outputFile": "StructureDefinition-mii-pr-onko-genetische-variante.json",
"fshName": "MII_PR_Onko_Genetische_Variante",
"fshType": "Profile",
"fshFile": "oBDS\\23_GenetischeVariante\\mii-pr-onko-genetische-variante.fsh",
"startLine": 1,
"endLine": 33
"endLine": 43
},
{
"outputFile": "StructureDefinition-mii-pr-onko-grading.json",
"fshName": "MII_PR_Onko_Grading",
"fshType": "Profile",
"fshFile": "oBDS\\06_Histologie\\mii-pr-onko-grading.fsh",
"startLine": 2,
"endLine": 49
"endLine": 52
},
{
"outputFile": "StructureDefinition-mii-pr-onko-histologie-icdo3.json",
"fshName": "MII_PR_Onko_Histologie_ICDO3",
"fshType": "Profile",
"fshFile": "oBDS\\06_Histologie\\mii-pr-onko-histologie-icdo3.fsh",
"startLine": 1,
"endLine": 46
"endLine": 51
},
{
"outputFile": "StructureDefinition-mii-pr-onko-liste-evidenz-erstdiagnose.json",
Expand All @@ -1349,191 +1357,191 @@
"fshType": "Profile",
"fshFile": "oBDS\\15_Nebenwirkung_ST_SYST\\mii-pr-onko-nebenwirkung-adverseEvent.fsh",
"startLine": 1,
"endLine": 36
"endLine": 42
},
{
"outputFile": "StructureDefinition-mii-pr-onko-operation.json",
"fshName": "MII_PR_Onko_Operation",
"fshType": "Profile",
"fshFile": "oBDS\\13_OP\\mii-pr-onko-operation.fsh",
"startLine": 1,
"endLine": 65
"endLine": 73
},
{
"outputFile": "StructureDefinition-mii-pr-onko-residualstatus.json",
"fshName": "MII_PR_Onko_Residualstatus",
"fshType": "Profile",
"fshFile": "oBDS\\10_Residualstatus\\mii-pr-onko-residualstatus.fsh",
"startLine": 1,
"endLine": 49
"endLine": 51
},
{
"outputFile": "StructureDefinition-mii-pr-onko-specimen.json",
"fshName": "MII_PR_Onko_Specimen",
"fshType": "Profile",
"fshFile": "oBDS\\06_Histologie\\mii-pr-onko-specimen.fsh",
"startLine": 1,
"endLine": 16
"endLine": 22
},
{
"outputFile": "StructureDefinition-mii-pr-onko-strahlentherapie.json",
"fshName": "MII_PR_Onko_Strahlentherapie",
"fshType": "Profile",
"fshFile": "oBDS\\14_Strahlentherapie\\mii-pr-onko-strahlentherapie.fsh",
"startLine": 1,
"endLine": 54
"endLine": 95
},
{
"outputFile": "StructureDefinition-mii-pr-onko-studienteilnahme.json",
"fshName": "MII_PR_Onko_Studienteilnahme",
"fshType": "Profile",
"fshFile": "oBDS\\24_Studienteilnahme\\mii-pr-onko-studienteilnahme.fsh",
"startLine": 1,
"endLine": 36
"endLine": 40
},
{
"outputFile": "StructureDefinition-mii-pr-onko-systemische-therapie-medikation.json",
"fshName": "MII_PR_Onko_Systemische_Therapie_Medikation",
"fshType": "Profile",
"fshFile": "oBDS\\16_SystemischeTherapie\\mii-pr-onko-systemische-therapie-medikation.fsh",
"startLine": 1,
"endLine": 33
"endLine": 48
},
{
"outputFile": "StructureDefinition-mii-pr-onko-systemische-therapie.json",
"fshName": "MII_PR_Onko_Systemische_Therapie",
"fshType": "Profile",
"fshFile": "oBDS\\16_SystemischeTherapie\\mii-pr-onko-systemische-therapie.fsh",
"startLine": 1,
"endLine": 53
"endLine": 71
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-a-symbol.json",
"fshName": "MII_PR_Onko_TNM_a_Symbol",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-a-symbol.fsh",
"startLine": 1,
"endLine": 36
"endLine": 42
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-klassifikation.json",
"fshName": "MII_PR_Onko_TNM_Klassifikation",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-klassifikation.fsh",
"startLine": 1,
"endLine": 42
"endLine": 51
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-l-kategorie.json",
"fshName": "MII_PR_Onko_TNM_L_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-l-kategorie.fsh",
"startLine": 1,
"endLine": 38
"endLine": 43
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-m-kategorie.json",
"fshName": "MII_PR_Onko_TNM_M_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-m-kategorie.fsh",
"startLine": 1,
"endLine": 52
"endLine": 58
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-m-symbol.json",
"fshName": "MII_PR_Onko_TNM_m_Symbol",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-m-symbol.fsh",
"startLine": 1,
"endLine": 35
"endLine": 40
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-n-kategorie.json",
"fshName": "MII_PR_Onko_TNM_N_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-n-kategorie.fsh",
"startLine": 1,
"endLine": 52
"endLine": 58
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-pn-kategorie.json",
"fshName": "MII_PR_Onko_TNM_Pn_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-pn-kategorie.fsh",
"startLine": 1,
"endLine": 38
"endLine": 44
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-r-symbol.json",
"fshName": "MII_PR_Onko_TNM_r_Symbol",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-r-symbol.fsh",
"startLine": 1,
"endLine": 34
"endLine": 40
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-s-kategorie.json",
"fshName": "MII_PR_Onko_TNM_S_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-s-kategorie.fsh",
"startLine": 1,
"endLine": 39
"endLine": 45
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-t-kategorie.json",
"fshName": "MII_PR_Onko_TNM_T_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-t-kategorie.fsh",
"startLine": 1,
"endLine": 43
"endLine": 48
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-v-kategorie.json",
"fshName": "MII_PR_Onko_TNM_V_Kategorie",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-v-kategorie.fsh",
"startLine": 1,
"endLine": 37
"endLine": 42
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tnm-y-symbol.json",
"fshName": "MII_PR_Onko_TNM_y_Symbol",
"fshType": "Profile",
"fshFile": "oBDS\\08_TNMKlassifikation\\mii-pr-onko-tnm-y-symbol.fsh",
"startLine": 1,
"endLine": 35
"endLine": 41
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tod.json",
"fshName": "MII_PR_Onko_Tod",
"fshType": "Profile",
"fshFile": "oBDS\\20_Tod\\mii-pr-onko-tod.fsh",
"startLine": 1,
"endLine": 42
"endLine": 49
},
{
"outputFile": "StructureDefinition-mii-pr-onko-tumorkonferenz.json",
"fshName": "MII_PR_Onko_Tumorkonferenz",
"fshType": "Profile",
"fshFile": "oBDS\\18_19_Tumorkonferenz\\mii-pr-onko-tumorkonferenz.fsh",
"startLine": 1,
"endLine": 50
"endLine": 59
},
{
"outputFile": "StructureDefinition-mii-pr-onko-verlauf.json",
"fshName": "MII_PR_Onko_Verlauf",
"fshType": "Profile",
"fshFile": "oBDS\\17_Verlauf\\mii-pr-onko-verlauf.fsh",
"startLine": 1,
"endLine": 70
"endLine": 85
},
{
"outputFile": "StructureDefinition-mii-pr-onko-weitere-klassifikationen.json",
"fshName": "MII_PR_Onko_Weitere_Klassifikationen",
"fshType": "Profile",
"fshFile": "oBDS\\09_Weitere_Klassifikationen\\mii-pr-onko-weitere-klassifikationen.fsh",
"startLine": 1,
"endLine": 32
"endLine": 45
},
{
"outputFile": "ValueSet-mii-vs-onko-allgemeiner-leistungszustand-ecog.json",
Expand Down
Loading
Loading